COCH
Envoy Medical, Inc. Class A Common Stock
Nasdaq · usd
Envoy Medical, Inc. Class A Common Stock (COCH) trades at $6.74 (-1.10%) as of 7:30:01 PM EST on Nov 13, 2026, +4.47% over the past month. Market cap is $52.16M, with 2.7 days to cover in short interest.
Stock performance
How Envoy Medical, Inc. Class A Common Stock (COCH) stock has performed from one day to one year, with its 52-week range.
- 1D
- -1.10%
- 1W
- -5.80%
- 1M
- +4.47%
- YTD
- +1.88%
- 1Y
- +3.28%
- 52-wk range
- $3.63 – $9.54
Key statistics
Today's trading snapshot for COCH: day range, open, previous close, volume and market cap.
- Day range
- $6.50 – $6.92
- Open
- $6.60
- Prev close
- $6.81
- Volume
- 10.03K
- Market cap
- $52.16M
- Shares out
- 7.74M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Envoy Medical, Inc. Class A Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 225.96
- P/B
- -34.09
- P/FCF
- —
- ROE
- 1695.0%
- ROA
- -135.5%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Nov 13, 2026
8-K filings
Material corporate events Envoy Medical, Inc. Class A Common Stock has disclosed to the SEC on Form 8-K.
- Quarterly earningsNov 5, 2026
On November 5, 2026, Envoy Medical, Inc. (the "Company"), issued a press release regarding the Company's financial results for its fiscal quarter ended September 30, 2026.
- Charter amendmentOct 27, 2026
On October 23, 2026, Envoy Medical, Inc. ... filed a certificate of amendment to the Company's Second Amended and Restated Certificate of Incorporation ... to effectuate a 1-for-10 reverse stock split.
- Charter amendmentOct 16, 2026
"the Company's stockholders... voted to approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation to, at the discretion of the Board of Directors, effect one or more reverse stock splits with respect to our issued and outstanding Class A Common Stock... at a ratio of 1-for-5 to 1-for-25"
- Settlement agreementOct 7, 2026
On October 6, 2026, Envoy Medical, Inc. entered into a Dismissal Agreement regarding litigation in the Delaware Court of Chancery (the "Litigation") with Atlas Merchant Capital SPAC Fund I LP. Pursuant to the terms of the Dismissal Agreement, all of Atlas' claims will be dismissed with prejudice, and there will be no further proceedings in relation to the Litigation; neither the Company nor any other defendant will be required to make a payment to Atlas under the Dismissal Agreement.
- Executive compensation changeAug 27, 2026
Pursuant to the terms of the Employment Agreement, Mr. Potashnick is entitled to a base salary of $315,000 per year, an initial target bonus equal to 15% of his base salary payable upon the Company's achievement of certain performance goals, and an initial equity award of 250,000 stock options at an exercise price of $0.746 per share, the closing price of the Company's Class A Common Stock on the hire date. The Employment Agreement also provides for six months of severance compensation in connection with certain terminations of Mr. Potashnick's employment.
Dividend history and stock splits
Envoy Medical, Inc. Class A Common Stock's recent dividend payments and stock splits.
Dividends
No recent dividends.
Splits
- 1-for-10Oct 26, 2026
COCH short interest
How heavily COCH is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 2.7
- Short interest
- 89.92K
- Avg volume
- 33.64K
As of · reported to FINRA twice monthly.
COCH news
The latest news and headlines about Envoy Medical, Inc. Class A Common Stock (COCH).
- Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue EstimatesneutralZacks Investment Research· Nov 4, 2026
- EdgarAgents Debuts EA34 Plugin at Centri Capital Conference to Simplify and Expedite Financial Filing Process for Mid-to-Microcap CompaniesneutralGlobeNewswire Inc.· Apr 22, 2025
- Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing DevicepositiveGlobeNewswire Inc.· Nov 1, 2024
- Envoy Medical Announces Inclusion in the MSCI USA Micro Cap Index GlobeNewswire Inc.· Jun 6, 2024
- Envoy Medical Reports First Quarter 2024 ResultsGlobeNewswire Inc.· May 15, 2024
Frequently asked questions
What is the Envoy Medical, Inc. Class A Common Stock (COCH) stock price today?
Envoy Medical, Inc. Class A Common Stock (COCH) is trading at $6.74 (-1.10% on the day) as of 7:30:01 PM EST on Nov 13, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Envoy Medical, Inc. Class A Common Stock?
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is…
What is the short interest in COCH?
As of Oct 30, 2026, COCH has 89.92K shares short and 2.7 days to cover.
What exchange is COCH listed on?
Envoy Medical, Inc. Class A Common Stock (COCH) trades on Nasdaq in USD, in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES industry.
Build with AI
Build an analysis of COCH with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a COCH analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.